CORPORATE STARATEGY

Global leader of Cell Therapy – “Cell A-to-Z”

We’d like to become a global leader in the Cell Therapy Industry leveraging with proprietary therapeutic cells and unique platform technologies

We’d like to become a global leader in the Cell Therapy Industry leveraging with proprietary therapeutic cells and unique platform technologies

A-to-Z Cells

  • ES-derived MSSC
  • iPS-derived MSSC
  • Schwann Cells
  • Muscle Cells
  • Immune Cells

A-to-Z Platforms

  • MSSC platform: original cells
  • Direct conversion
  • Chemical conversion
  • RNA-based modification
  • Automation